Grace Breeding (GRAC) Stock Overview
An agro-tech company, engages in the research and development in the area of biological substitutes for synthetic materials used in the fertilizer and growth promoter industries in Europe, the United States, South America, and Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
GRAC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Grace Breeding Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪17.56 |
| 52 Week High | ₪23.25 |
| 52 Week Low | ₪11.06 |
| Beta | 0.56 |
| 1 Month Change | -0.23% |
| 3 Month Change | -15.05% |
| 1 Year Change | 1.21% |
| 3 Year Change | 47.19% |
| 5 Year Change | n/a |
| Change since IPO | -34.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| GRAC | IL Biotechs | IL Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.4% |
| 1Y | 1.2% | 12.6% | 57.5% |
Return vs Industry: GRAC underperformed the IL Biotechs industry which returned 15.3% over the past year.
Return vs Market: GRAC underperformed the IL Market which returned 54.3% over the past year.
Price Volatility
| GRAC volatility | |
|---|---|
| GRAC Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.3% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in IL Market | 8.4% |
| 10% least volatile stocks in IL Market | 3.5% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine GRAC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 4 | Moore Zelkha | gracebreeding.com |
Grace Breeding Ltd, an agro-tech company, engages in the research and development in the area of biological substitutes for synthetic materials used in the fertilizer and growth promoter industries in Europe, the United States, South America, and Israel. The company also sells seeds. Its product portfolio includes Maoz, a biofertilizer that aids with photosynthesis; ProMagen, a combination of plant materials with anti-inflammatory properties for biotic stress tolerance; and ClimAid for abiotic stress tolerance.
Grace Breeding Ltd Fundamentals Summary
| GRAC fundamental statistics | |
|---|---|
| Market cap | ₪73.41m |
| Earnings (TTM) | -₪2.48m |
| Revenue (TTM) | n/a |
Is GRAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GRAC income statement (TTM) | |
|---|---|
| Revenue | ₪0 |
| Cost of Revenue | ₪0 |
| Gross Profit | ₪0 |
| Other Expenses | ₪2.48m |
| Earnings | -₪2.48m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did GRAC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/19 22:00 |
| End of Day Share Price | 2026/03/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Grace Breeding Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.